Patent ID: 6660299
Filing Date: 2003-12-09
Classification: A61K,A61P

Abstract:
A modified release pharmaceutical formulation comprising about 2000 mg of amoxycillin in an immediate release phase and a slow release phase;the immediate release phase comprising a first part of amoxycillin formulated with one or more pharmaceutically acceptable excipients which allows for immediate release of the first part of amoxycillin, and the slow release phase comprising a second part of amoxycillin formulated with one or more release modifying pharmaceutically acceptable excipients, wherein the ratio of amoxycillin in the immediate and slow release phase is from 3:1 to 1:3, and wherein the AUC value is at least 80% of that of the corresponding dosage of amoxycillin taken as an immediate release tablet or tablets, over the same dosage period.